In brain tumor initiating cells [10], [11], hypomethylation of the SOX2 promoter has been directly correlated with SOX2 expression, and the SOX2 promoter is hypomethylated in aggressive glioblastoma patient samples [12]. The gene discussed is SOX2; the disease is glioblastoma.